Creative Planning - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 11 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Creative Planning ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q3 2022$10,0000.0%10,0000.0%0.00%
Q2 2022$10,0000.0%10,0000.0%0.00%
Q1 2022$10,0000.0%10,0000.0%0.00%
Q4 2021$10,0000.0%10,0000.0%0.00%
Q3 2021$10,0000.0%10,0000.0%0.00%
Q2 2021$10,0000.0%10,0000.0%0.00%
Q1 2021$10,0000.0%10,0000.0%0.00%
Q4 2020$10,0000.0%10,0000.0%0.00%
Q3 2020$10,0000.0%10,0000.0%0.00%
Q2 2020$10,000
+11.1%
10,0000.0%0.00%
Q1 2020$9,0000.0%10,0000.0%0.00%
Q4 2019$9,0000.0%10,0000.0%0.00%
Q3 2019$9,0000.0%10,0000.0%0.00%
Q2 2019$9,0000.0%10,0000.0%0.00%
Q1 2019$9,0000.0%10,0000.0%0.00%
Q4 2018$9,0000.0%10,0000.0%0.00%
Q3 2018$9,0000.0%10,0000.0%0.00%
Q2 2018$9,0000.0%10,0000.0%0.00%
Q1 2018$9,000
-50.0%
10,000
-50.0%
0.00%
Q4 2017$18,000
+125.0%
20,000
+233.3%
0.00%
Q1 2016$8,000
-11.1%
6,0000.0%0.00%
Q4 2015$9,0006,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q3 2021
NameSharesValueWeighting ↓
Southpaw Asset Management LP 20,000,000$17,675,00025.38%
INCOME RESEARCH & MANAGEMENT 23,109,000$20,278,0005.29%
Fore Capital, LLC 5,000,000$4,430,0001.71%
RIVERHEAD CAPITAL MANAGEMENT LLC 20,000,000$17,603,0000.74%
ARISTEIA CAPITAL, L.L.C. 18,500,000$16,361,0000.70%
ZAZOVE ASSOCIATES LLC 11,153,000$9,843,0000.58%
BASSO CAPITAL MANAGEMENT, L.P. 3,600,000$3,182,0000.52%
CSS LLC/IL 10,450,000$9,240,0000.45%
Lombard Odier Asset Management (Europe) Ltd 7,950,000$7,038,0000.44%
Wellesley Asset Management 6,740$5,948,0000.31%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders